Cardiff Oncology shares plunge after Q2 earnings miss
Director Farquhar Scott of Atlassian Corp (NASDAQ:TEAM), the software giant currently valued at $52.5 billion with impressive gross profit margins of 82%, sold 9,665 shares of Class A Common Stock on July 23, 2025, for a total of $1.55 million. According to InvestingPro analysis, the stock is currently trading near its Fair Value. The sales were executed in multiple trades at prices ranging from $197.1322 to $204.583.
The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2025. The shares are held by Farquhar Investment Partnership No. 2. Following the transactions, Farquhar Scott indirectly owns 367,920 shares of Atlassian Corp. With analysts setting price targets ranging from $211 to $480 and maintaining a strong buy consensus, InvestingPro subscribers can access 8 additional key insights about TEAM’s valuation and growth prospects in the comprehensive Pro Research Report.
In other recent news, Atlassian Corporation has been the subject of several notable developments. Cantor Fitzgerald adjusted its price target for Atlassian shares to $256, down from $272, following third-quarter fiscal year 2025 results that met expectations but revealed a shortfall in billings due to fewer multi-year Data Center deals. Stephens also revised its price target for Atlassian, reducing it to $221 from $255, citing third-quarter performance that fell short of high market expectations. Additionally, Moody’s Ratings upgraded Atlassian’s senior unsecured notes to Baa2, maintaining a stable outlook and anticipating a 20% or more revenue growth over the next 12 to 24 months, driven by cloud subscription revenues.
Meanwhile, Capital One (NYSE:COF) downgraded Atlassian from Overweight to Equal-weight, citing concerns over AI competition and valuation challenges. In contrast, Bernstein reiterated an Outperform rating with a $310 price target, despite ongoing investor debate about the company’s guidance. These recent developments highlight differing perspectives among analysts and rating agencies regarding Atlassian’s financial health and future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.